SCHEMBL8463173

SCHEMBL8463173

O=C(NN1CC2CCCC2C1)C1=NN(c2ccc(Cl)cc2Cl)C(c2ccc(Br)s2)C1

nearest known ligand 0.54

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 20/20 0.54
CNR2 P34972 14/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4606543 0.89 CNR1 (0.59) CNR1CNR2
SCHEMBL8473316 0.87 CNR1 (0.54) CNR1CNR2
SCHEMBL8469772 0.86 CNR1 (0.56) CNR1CNR2
SCHEMBL2020468 0.85 CNR1 (0.67) CNR1CNR2
SCHEMBL5274930 0.85 CNR1 (0.67) CNR1CNR2
SCHEMBL5275124 0.85 CNR1 (0.67) CNR1CNR2
SCHEMBL4605643 0.85 CNR1 (0.48) CNR1CNR2
SCHEMBL4605624 0.85 CNR1 (0.74) CNR1CNR2
SCHEMBL2018426 0.85 CNR1 (0.74) CNR1CNR2
SCHEMBL2018661 0.85 CNR1 (0.74) CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1946778-A1 Active substance combination for the treatment of diabetes Laboratorios del Dr. Esteve S.A. (ES) 2008-07-23 EP disclosed
EP-1743894-A1 Heterocyclyl-substituted pyrazoline compounds, their preparation and use as medicaments LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-01-17 EP disclosed